Author presents Budget 2026 long theses for four listed Indian companies: TD Power Systems, Ircon International, NMDC, and Biocon.
TDPOWERSYS — LONG The author argues TD Power Systems is well placed for data center and power demand because it manufactures generators, alternators, and power systems critical for data centers and captive power plants. The 2026 Budget extends a tax holiday to 2047 for foreign cloud/data center investment in India, which the author sees as a massive tailwind. Strong export orders from Europe and the US and management's raised FY27 revenue guidance are cited as additional catalysts.
They manufacture generators, alternators, and power systems that are critical for data centers and captive power plants.
IRCON — LONG The author calls Ircon International a direct play on railway infrastructure because it specializes in railway construction, electrification, and large infrastructure projects. The Budget announced seven new high-speed rail corridors and increased railway capital expenditure to roughly Rs 2.8 lakh crore, with new-line allocation up significantly. The author expects a steady stream of meaningful contracts to flow into the order book over the next couple of years.
Since Ircon specializes in railway construction, electrification, and large infrastructure projects, they should see a steady stream of meaningful contracts flowing into their order book over the next couple of years.
NMDC — LONG The author argues NMDC Ltd stands to benefit from the government's focus on critical minerals and rare earths. Dedicated 'Rare Earth Corridors' are planned in mineral-rich states including Odisha, Andhra Pradesh, and Tamil Nadu to boost domestic mining and reduce import dependence. As a large public sector miner with established operations in these regions, NMDC is positioned to expand beyond iron ore and take a leadership role in this strategic area.
As a large public sector miner with established operations in these regions, NMDC is in a prime position to expand beyond just iron ore and take a leadership role in this new strategic area.
BIOCON — LONG The author sees Biocon as one of the biggest pharma/biotech winners from the budget due to the new Biopharma SHAKTI scheme with Rs 10,000 crore outlay. The scheme aims to make India a global hub for biologics and biosimilars through domestic manufacturing, R&D, and clinical trials. Since Biocon is already India's leading player in biosimilars and complex biologics, this direct policy support should help it scale faster and capture more market share.
Biocon is already India’s leading player in biosimilars and complex biologics, so this direct policy support and funding should help them scale faster and capture more market share in a rapidly growing segment.
This Reddit post, published February 02, 2026, features u/JoTumMereHo discussing TDPOWERSYS, IRCON, NMDC.NS, BIOCON.NS. 4 trade ideas extracted by AI with direction and confidence scoring.
Speakers: u/JoTumMereHo · Tickers: TDPOWERSYS, IRCON, NMDC.NS, BIOCON.NS